ZAGREB, Sept 3 (Hina) - Dechra Pharmaceuticals, a leading British veterinary medicine producer, stated on Monday that it shifted all the analytical testing methods for products made at its site in Skipton, England, to a new lab in Zagreb, and to its existing Bladel laboratory in the Netherlands, as part of the company's preparations for "a potential hard Brexit", Reuters has reported.
Dechra, braced for Brexit, moves testing operations to Croatia and Netherlands
Only logged-in users can see full content details